<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23855481</PMID><DateCompleted><Year>2014</Year><Month>03</Month><Day>03</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2013</Year><Month>Jul</Month><Day>15</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Seroepidemiology of human enterovirus71 and coxsackievirusA16 among children in Guangdong province, China.</ArticleTitle><Pagination><StartPage>322</StartPage><MedlinePgn>322</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/1471-2334-13-322</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hand, foot and mouth disease (HFMD) is a common pediatric illness. Mainly induced by the Enterovirus 71 and Coxsackievirus A 16 infections, the frequently occurred HFMD outbreaks have become a serious public health problem in Southeast Asia. Currently,only a few studies have investigated the human immunity to HFMD in China. In this study, we conducted a cohort study in Guangdong province, China.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Stored serum samples from children less than 10 years old were analyzed. The levels of EV71 and CA16 specific antibodies before, during and shortly after the 2008 large outbreak of HFMD were evaluated by the microneutralization test. The geometric mean titer (GMT) was calculated and compared. Statistical significance was taken as P&#x2009;&lt;&#x2009;0.05.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The seroprevalence data showed a continuous circulation of EV71 and CA16 in Guangdong province China in 2007-2009. The low positive rate in 2009 correlated well with the unprecedented outbreak of HFMD in 2010. Age related increase of seroprevalence was identified in 1-3 years old children for EV71 and in 1-5 years old children for CA16 in Guangdong province. High GMT of EV71 and CA16 antibody titers were also found for these age groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">All of the above findings indicated common infections for these age groups. And they should clearly be at the top of the priority in periodical seroprevalence survey and future vaccination campaign.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Pathogen Detection Research for Emerging Infectious Diseases, Center for Disease Control and Prevention of Guangdong Province, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yi</LastName><ForeName>Lina</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Juan</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Jing</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Hanri</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Guan</LastName><ForeName>Dawei</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Cong</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wanly</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Hong</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Hui</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yonghui</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Jinyan</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Ke</LastName><ForeName>Changwen</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>07</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2013</Year><Month>7</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23855481</ArticleId><ArticleId IdType="pmc">PMC3717138</ArticleId><ArticleId IdType="doi">10.1186/1471-2334-13-322</ArticleId><ArticleId IdType="pii">1471-2334-13-322</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yi L, Lu J, Kung HF, He ML. The virology and developments toward control of human enterovirus 71. Crit Rev Microbiol. 2011;37(4):313&#x2013;327. doi: 10.3109/1040841X.2011.580723.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/1040841X.2011.580723</ArticleId><ArticleId IdType="pubmed">21651436</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10(11):778&#x2013;790. doi: 10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiung GD, Wang JR. Enterovirus infections with special reference to enterovirus 71. J Microbiol Immunol Infect. 2000;33(1):1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">10806956</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen SC, Chang HL, Yan TR, Cheng YT, Chen KT. An eight-year study of epidemiologic features of enterovirus 71 infection in Taiwan. Am J Trop Med Hyg. 2007;77(1):188&#x2013;191.</Citation><ArticleIdList><ArticleId IdType="pubmed">17620652</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev. 2002;26(1):91&#x2013;107. doi: 10.1111/j.1574-6976.2002.tb00601.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6976.2002.tb00601.x</ArticleId><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Koroleva GA, Lukashev AN, Khudiakova LV, Mustafina AN, Lashkevich VA. Encephalomyelitis caused by enterovirus type 71 in children. Vopr Virusol. 2011;55(6):4&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">21381332</ArticleId></ArticleIdList></Reference><Reference><Citation>Denizot M, Neal JW, Gasque P. Encephalitis due to emerging viruses: CNS innate immunity and potential therapeutic targets. J Infect. 2012;65(1):1&#x2013;16. doi: 10.1016/j.jinf.2012.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2012.03.019</ArticleId><ArticleId IdType="pubmed">22484271</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P, Stratov I, Nagarajan L, Davis S. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis. 2001;32(2):236&#x2013;242. doi: 10.1086/318454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/318454</ArticleId><ArticleId IdType="pubmed">11170913</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih SR, Stollar V, Li ML. Host factors in enterovirus 71 replication. J Virol. 2011;85(19):9658&#x2013;9666. doi: 10.1128/JVI.05063-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.05063-11</ArticleId><ArticleId IdType="pmc">PMC3196451</ArticleId><ArticleId IdType="pubmed">21715481</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki Y, Taya K, Nakashima K, Ohyama T, Kobayashi JM, Ohkusa Y, Okabe N. Risk factors for severe hand foot and mouth disease. Pediatr Int. 2009;52(2):203&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">19663940</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MS, Chiang PS, Luo ST, Huang ML, Liou GY, Tsao KC, Lin TY. Incidence rates of enterovirus 71 infections in young children during a nationwide epidemic in Taiwan, 2008&#x2013;09. PLoS Negl Trop Dis. 2012;6(2):e1476. doi: 10.1371/journal.pntd.0001476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001476</ArticleId><ArticleId IdType="pmc">PMC3279337</ArticleId><ArticleId IdType="pubmed">22348156</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu PV, Thao NT, Perera D, Huu TK, Tien NT, Thuong TC, How OM, Cardosa MJ, McMinn PC. Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005. Emerg Infect Dis. 2007;13(11):1733&#x2013;1741. doi: 10.3201/eid1311.070632.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1311.070632</ArticleId><ArticleId IdType="pmc">PMC3375788</ArticleId><ArticleId IdType="pubmed">18217559</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei SH, Huang YP, Liu MC, Tsou TP, Lin HC, Lin TL, Tsai CY, Chao YN, Chang LY, Hsu CM. An outbreak of coxsackievirus A6 hand, foot, and mouth disease associated with onychomadesis in Taiwan, 2010. BMC Infect Dis. 2011;11:346. doi: 10.1186/1471-2334-11-346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-11-346</ArticleId><ArticleId IdType="pmc">PMC3297538</ArticleId><ArticleId IdType="pubmed">22168544</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirand A, Henquell C, Archimbaud C, Ughetto S, Antona D, Bailly JL, Peigue-Lafeuille H. Outbreak of hand, foot and mouth disease/herpangina associated with coxsackievirus A6 and A10 infections in 2010, France: a large citywide, prospective observational study. Clin Microbiol Infect. 2012;18(5):E110&#x2013;118. doi: 10.1111/j.1469-0691.2012.03789.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-0691.2012.03789.x</ArticleId><ArticleId IdType="pubmed">22404077</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwai M, Masaki A, Hasegawa S, Obara M, Horimoto E, Nakamura K, Tanaka Y, Endo K, Tanaka K, Ueda J. et al.Genetic changes of coxsackievirus A16 and enterovirus 71 isolated from hand, foot, and mouth disease patients in Toyama, Japan between 1981 and 2007. Jpn J Infect Dis. 2009;62(4):254&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">19628900</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Yeo A, Phoon MC, Tan EL, Poh CL, Quak SH, Chow VT. The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains. Int J Infect Dis. 2010;14(12):e1076&#x2013;1081. doi: 10.1016/j.ijid.2010.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2010.07.006</ArticleId><ArticleId IdType="pubmed">20952237</ArticleId></ArticleIdList></Reference><Reference><Citation>Ang LW, Koh BK, Chan KP, Chua LT, James L, Goh KT. Epidemiology and control of hand, foot and mouth disease in Singapore, 2001&#x2013;2007. Ann Acad Med Singapore. 2009;38(2):106&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">19271036</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan D, van der Sanden S, Zeng H, Li W, Zheng H, Ma C, Su J, Liu Z, Guo X, Zhang X. et al.Population dynamics and genetic diversity of C4 strains of human enterovirus 71 in Mainland China, 1998&#x2013;2010. PLoS One. 2012;7(9):e44386. doi: 10.1371/journal.pone.0044386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0044386</ArticleId><ArticleId IdType="pmc">PMC3440427</ArticleId><ArticleId IdType="pubmed">22984501</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun LM, Zheng HY, Zheng HZ, Guo X, He JF, Guan DW, Kang M, Liu Z, Ke CW, Li JS. et al.An enterovirus 71 epidemic in Guangdong Province of China, 2008: epidemiological, clinical, and virogenic manifestations. Jpn J Infect Dis. 2011;64(1):13&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">21266750</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan LG, Parashar UD, Lye MS, Ong FG, Zaki SR, Alexander JP, Ho KK, Han LL, Pallansch MA, Suleiman AB. et al.Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For Outbreak Study Group Clin Infect Dis. 2000;31(3):678&#x2013;683. doi: 10.1086/314032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/314032</ArticleId><ArticleId IdType="pubmed">11017815</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MS, Lin TY, Chiang PS, Li WC, Luo ST, Tsao KC, Liou GY, Huang ML, Hsia SH, Huang YC. et al.An investigation of epidemic enterovirus 71 infection in Taiwan, 2008: clinical, virologic, and serologic features. Pediatr Infect Dis J. 2010;29(11):1030&#x2013;1034.</Citation><ArticleIdList><ArticleId IdType="pubmed">20543760</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention, Taiwan. Deaths among children during an outbreak of hand, foot, and mouth disease--Taiwan, Republic of China, April-July 1998. MMWR Morb Mortal Wkly Rep. 1998;47(30):629&#x2013;632.</Citation><ArticleIdList><ArticleId IdType="pubmed">9704628</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Sun J, Chang Z, Zhang W, Wang Z, Feng Z. Characterization of hand, foot, and mouth disease in China between 2008 and 2009. Biomed Environ Sci. 2011;24(3):214&#x2013;221.</Citation><ArticleIdList><ArticleId IdType="pubmed">21784305</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan X, Huang X, Zhu S, Chen H, Yu Q, Wang H, Huo X, Zhou J, Wu Y, Yan D. et al.The persistent circulation of enterovirus 71 in People's Republic of China: causing emerging nationwide epidemics since 2008. PLoS One. 2011;6(9):e25662. doi: 10.1371/journal.pone.0025662.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0025662</ArticleId><ArticleId IdType="pmc">PMC3181342</ArticleId><ArticleId IdType="pubmed">21980521</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu MY, Liu W, Luo J, Liu Y, Zhu Y, Berman H, Wu J. Characterization of an outbreak of hand, foot, and mouth disease in Nanchang, China in 2010. PLoS One. 2011;6(9):e25287. doi: 10.1371/journal.pone.0025287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0025287</ArticleId><ArticleId IdType="pmc">PMC3182205</ArticleId><ArticleId IdType="pubmed">21980416</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan XF, Gao S, Xia JF, Ye R, Yu H, Long JE. Epidemic characteristics of hand, foot, and mouth disease in Shanghai from 2009 to 2010: Enterovirus 71 subgenotype C4 as the primary causative agent and a high incidence of mixed infections with coxsackievirus A16. Scand J Infect Dis. 2011;44(4):297&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pubmed">22176514</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji H, Li L, Liu Y, Ge H, Wang X, Hu J, Wu B, Fu J, Zhang Z, Chen X. et al.Seroepidemiology of human enterovirus71 and coxsackievirusA16 in Jiangsu province. China Virol J. 2012;9(1):248. doi: 10.1186/1743-422X-9-248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-9-248</ArticleId><ArticleId IdType="pmc">PMC3545860</ArticleId><ArticleId IdType="pubmed">23102275</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng M, El Khatib NF, Tu S, Ren P, Xu S, Zhu Q, Mo X, Pu D, Wang X, Altmeyer R. Seroepidemiology of Enterovirus 71 infection prior to the 2011 season in children in Shanghai. J Clin Virol. 2012;53(4):285&#x2013;289. doi: 10.1016/j.jcv.2011.12.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2011.12.025</ArticleId><ArticleId IdType="pubmed">22265829</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q, Dong C, Li X, Gao Q, Guo Z, Yao X, Wang Y, Gao F, Li F, Xu M. et al.Comparative analysis of the immunogenicity and protective effects of inactivated EV71 vaccines in mice. PLoS One. 2012;7(9):e46043. doi: 10.1371/journal.pone.0046043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0046043</ArticleId><ArticleId IdType="pmc">PMC3460965</ArticleId><ArticleId IdType="pubmed">23029378</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MS, Tseng FC, Wang JR, Chi CY, Chong P, Su IJ. Challenges to licensure of enterovirus 71 vaccines. PLoS Negl Trop Dis. 2012;6(8):e1737. doi: 10.1371/journal.pntd.0001737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001737</ArticleId><ArticleId IdType="pmc">PMC3429393</ArticleId><ArticleId IdType="pubmed">22953003</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Z, Mao Q, Gao Q, Li X, Dong C, Yu X, Yao X, Li F, Yin W, Li Q. et al.Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines. Vaccine. 2011;29(52):9668&#x2013;9674. doi: 10.1016/j.vaccine.2011.10.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.10.018</ArticleId><ArticleId IdType="pubmed">22015395</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng FY, Li JX, Li XL, Chu K, Zhang YT, Ji H, Li L, Liang ZL, Zhu FC. Tolerability and immunogenicity of an inactivated enterovirus 71 vaccine in Chinese healthy adults and children: an open label, phase 1 clinical trial. Hum Vaccin Immunother. 2012;8(5):668&#x2013;674. doi: 10.4161/hv.19521.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.19521</ArticleId><ArticleId IdType="pubmed">22634437</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YP, Liang ZL, Gao Q, Huang LR, Mao QY, Wen SQ, Liu Y, Yin WD, Li RC, Wang JZ. Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, Phase I clinical trial. Vaccine. 2012;30(22):3295&#x2013;3303. doi: 10.1016/j.vaccine.2012.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2012.03.010</ArticleId><ArticleId IdType="pubmed">22426327</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabenau HF, Richter M, Doerr HW. Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany. Med Microbiol Immunol. 2009;199(1):45&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">19941005</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarr AW, Urbanowicz RA, Ball JK. The role of humoral innate immunity in hepatitis C virus infection. Viruses. 2012;4(1):1&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3280516</ArticleId><ArticleId IdType="pubmed">22355450</ArticleId></ArticleIdList></Reference><Reference><Citation>Minor PD. The polio-eradication programme and issues of the end game. J Gen Virol. 2011;93(Pt 3):457&#x2013;474.</Citation><ArticleIdList><ArticleId IdType="pubmed">22128250</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham RS. Relevance of antibody testing in patients with recurrent infections. J Allergy Clin Immunol. 2012;130(2):558&#x2013;559. doi: 10.1016/j.jaci.2012.06.013. e556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2012.06.013</ArticleId><ArticleId IdType="pubmed">22846755</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Y, Zhou X, Yang E, Pu J, Che Y, Wang J, Ma N, Liu L, Ding D, Tang D. et al.Analysis of the Th1/Th2 reaction in the immune response induced by EV71 inactivated vaccine in neonatal rhesus monkeys. J Clin Immunol. 2012;32(5):1048&#x2013;1058. doi: 10.1007/s10875-012-9690-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-012-9690-3</ArticleId><ArticleId IdType="pubmed">22585051</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q, Li N, Yu X, Yao X, Li F, Lu F, Zhuang H, Liang Z, Wang J. Antigenicity, animal protective effect and genetic characteristics of candidate vaccine strains of enterovirus 71. Arch Virol. 2011;157(1):37&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">21984267</ArticleId></ArticleIdList></Reference><Reference><Citation>Buxbaum S, Berger A, Preiser W, Rabenau HF, Doerr HW. Enterovirus infections in Germany: comparative evaluation of different laboratory diagnostic methods. Infection. 2001;29(3):138&#x2013;142. doi: 10.1007/s15010-001-1052-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-001-1052-7</ArticleId><ArticleId IdType="pubmed">11440383</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Wang X, Sun D, Ding S, Zhang B, Du Z, Xue F. Detecting Spatial-Temporal Clusters of HFMD from 2007 to 2011 in Shandong Province. China PLoS One. 2013;8(5):e63447. doi: 10.1371/journal.pone.0063447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0063447</ArticleId><ArticleId IdType="pmc">PMC3660332</ArticleId><ArticleId IdType="pubmed">23704909</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z, Zhu S, Guo X, Wang J, Wang D, Yan D, Tan X, Tang L, Zhu H, Yang Z. et al.Retrospective seroepidemiology indicated that human enterovirus 71 and coxsackievirus A16 circulated wildly in central and southern China before large-scale outbreaks from 2008. Virol J. 2010;7:300. doi: 10.1186/1743-422X-7-300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-7-300</ArticleId><ArticleId IdType="pmc">PMC2989968</ArticleId><ArticleId IdType="pubmed">21050463</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H, Wang M, Chang H, Lu J, Lu B, Li J, Chen W, Tang R, Gan L, Zhao J. et al.Prevalence of antibodies against enterovirus 71 in children from Lu'an City in Central China. Jpn J Infect Dis. 2011;64(6):528&#x2013;532.</Citation><ArticleIdList><ArticleId IdType="pubmed">22116336</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Q, Hao Y, Ma J, Yu S, Wang Y. Surveillance of hand, foot, and mouth disease in mainland China (2008&#x2013;2009) Biomed Environ Sci. 2011;24(4):349&#x2013;356.</Citation><ArticleIdList><ArticleId IdType="pubmed">22108323</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu SC, Hao YT, Zhang J, Xiao GX, Liu Z, Zhu Q, Ma JQ, Wang Y. Using interrupted time series design to analyze changes in hand, foot, and mouth disease incidence during the declining incidence periods of 2008&#x2013;2010 in China. Biomed Environ Sci. 2012;25(6):645&#x2013;652.</Citation><ArticleIdList><ArticleId IdType="pubmed">23228834</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Zhu R, Qian Y, Deng J, Sun Y, Liu L, Wang F, Zhao L. Comparing Enterovirus 71 with Coxsackievirus A16 by analyzing nucleotide sequences and antigenicity of recombinant proteins of VP1s and VP4s. BMC Microbiol. 2011;11:246. doi: 10.1186/1471-2180-11-246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2180-11-246</ArticleId><ArticleId IdType="pmc">PMC3217892</ArticleId><ArticleId IdType="pubmed">22050722</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang WC, Huang LM, Kao CL, Lu CY, Shao PL, Cheng AL, Fan TY, Chi H, Chang LY. Seroprevalence of enterovirus 71 and no evidence of crossprotection of enterovirus 71 antibody against the other enteroviruses in kindergarten children in Taipei city. J Microbiol Immunol Infect. 2011;45(2):96&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pubmed">22154997</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng T, Huang Y, Yu S, Gu J, Huang C, Xiao G, Hao Y. Spatial-temporal clusters and risk factors of hand, foot, and mouth disease at the district level in Guangdong Province. China PLoS One. 2013;8(2):e56943. doi: 10.1371/journal.pone.0056943.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0056943</ArticleId><ArticleId IdType="pmc">PMC3578924</ArticleId><ArticleId IdType="pubmed">23437278</ArticleId></ArticleIdList></Reference><Reference><Citation>Ang LW, Phoon MC, Wu Y, Cutter J, James L, Chow VT. The changing seroepidemiology of enterovirus 71 infection among children and adolescents in Singapore. BMC Infect Dis. 2011;11:270. doi: 10.1186/1471-2334-11-270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-11-270</ArticleId><ArticleId IdType="pmc">PMC3198955</ArticleId><ArticleId IdType="pubmed">21988931</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>